A mutation in the collagen type IV alpha-5 chain (COL4A5) gene is a genetic marker of CKD and is associated with Alport syndrome, a hereditary disease marked by kidney dysfunction and kidney fibrosis [76]. Here, COL4A5 is linked to Alport syndrome.